DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Skljarevski V. et al
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
Cephalalgia 2018;
38 (08) 1442-1454
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.